The shot will be used to protect against respiratory syncytial virus in older adults — a turning point in the six-decade-long vaccine effort.
First vaccine targeting RSV wins FDA approval. More are coming.
The shot will be used to protect against respiratory syncytial virus in older adults — a turning point in the six-decade-long vaccine effort.